tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (DE:DUL)
XETRA:DUL
Advertisement

Alnylam Pharma (DUL) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
€388.30
$51.93B
60.05%
22 Buy
5 Hold
0 Sell
Strong Buy
Incyte
$83.80
$16.36B
19.05
29.48%
8 Buy
10 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$407.79
$104.55B
29.12
-15.98%
15 Buy
10 Hold
0 Sell
Moderate Buy
Argenx Se
$799.56
$49.05B
37.43
47.10%
21 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$31.81
$19.59B
15.75
34.45%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioNTech SE
$102.06
$24.54B
-14.85%
12 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:DUL
Alnylam Pharma
404.60
146.50
56.76%
INCY
Incyte
84.73
19.29
29.48%
VRTX
Vertex Pharmaceuticals
407.37
-77.45
-15.98%
ARGX
Argenx Se
799.56
256.00
47.10%
GMAB
Genmab
31.81
8.15
34.45%
BNTX
BioNTech SE
102.30
-17.84
-14.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis